TY - JOUR
T1 - Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues
AU - Ge, Xijin
AU - Yamamoto, Shogo
AU - Tsutsumi, Shuichi
AU - Midorikawa, Yutaka
AU - Ihara, Sigeo
AU - Wang, San Ming
AU - Aburatani, Hiroyuki
N1 - Funding Information:
The authors are indebted to Hirokazu Taniguchi for help with tissue acquisition, Hiroko Meguro for technical assistance, Yoshitaka Hippo, Naoko Nishikawa, Chen Yongxin, and Guo Yongqiu for stimulating discussions and Jiang Fu for proofreading. This work was partially supported by Grants-in-Aid for Scientific Research (S) 16101006 from The Ministry of Education, Culture, Sports, Science and Technology, Japan (to H.A.), and Health and Labour Sciences Research Grants (to H.A.). This work has been supported in part by NIH and Daniel F. and Ada L. Rice Foundation (to S.M.W.).
PY - 2005/8
Y1 - 2005/8
N2 - A critical and difficult part of studying cancer with DNA microarrays is data interpretation. Besides the need for data analysis algorithms, integration of additional information about genes might be useful. We performed genome-wide expression profiling of 36 types of normal human tissues and identified 2503 tissue-specific genes. We then systematically studied the expression of these genes in cancers by reanalyzing a large collection of published DNA microarray datasets. We observed that the expression level of liver-specific genes in hepatocellular carcinoma (HCC) correlates with the clinically defined degree of tumor differentiation. Through unsupervised clustering of tissue-specific genes differentially expressed in tumors, we extracted expression patterns that are characteristic of individual cell types, uncovering differences in cell lineage among tumor subtypes. We were able to detect the expression signature of hepatoctyes in HCC, neuron cells in medulloblastoma, glia cells in glioma, basal and luminal epithelial cells in breast tumors, and various cell types in lung cancer samples. We also demonstrated that tissue-specific expression signatures are useful in locating the origin of metastatic tumors. Our study shows that integration of each gene's breadth of expression (BOE) in normal tissues is important for biological interpretation of the expression profiles of cancers in terms of tumor differentiation, cell lineage, and metastasis.
AB - A critical and difficult part of studying cancer with DNA microarrays is data interpretation. Besides the need for data analysis algorithms, integration of additional information about genes might be useful. We performed genome-wide expression profiling of 36 types of normal human tissues and identified 2503 tissue-specific genes. We then systematically studied the expression of these genes in cancers by reanalyzing a large collection of published DNA microarray datasets. We observed that the expression level of liver-specific genes in hepatocellular carcinoma (HCC) correlates with the clinically defined degree of tumor differentiation. Through unsupervised clustering of tissue-specific genes differentially expressed in tumors, we extracted expression patterns that are characteristic of individual cell types, uncovering differences in cell lineage among tumor subtypes. We were able to detect the expression signature of hepatoctyes in HCC, neuron cells in medulloblastoma, glia cells in glioma, basal and luminal epithelial cells in breast tumors, and various cell types in lung cancer samples. We also demonstrated that tissue-specific expression signatures are useful in locating the origin of metastatic tumors. Our study shows that integration of each gene's breadth of expression (BOE) in normal tissues is important for biological interpretation of the expression profiles of cancers in terms of tumor differentiation, cell lineage, and metastasis.
KW - BRCA1
KW - Breadth of expression
KW - DNA microarray data interpretation
KW - ESR1
KW - Tissue-specific gene
KW - Tumor differentiation
UR - http://www.scopus.com/inward/record.url?scp=21444445235&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=21444445235&partnerID=8YFLogxK
U2 - 10.1016/j.ygeno.2005.04.008
DO - 10.1016/j.ygeno.2005.04.008
M3 - Article
C2 - 15950434
AN - SCOPUS:21444445235
SN - 0888-7543
VL - 86
SP - 127
EP - 141
JO - Genomics
JF - Genomics
IS - 2
ER -